LMR Partners »

Engene Therapeutics shares owned by LMR Partners

Quarter-by-quarter ownership of Engene Therapeutics shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Engene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Engene Therapeutics held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Therapeutics by LMR Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $90k 310k 0.29

More positions owned by LMR Partners

Ishares Tr Core S&p500 Etf (IVV)
Vaneck Etf Trust Semiconductr Etf (SMH)
Spdr Gold Tr Gold Shs (GLD)
NVIDIA Corporation (NVDA)
Ishares Silver Tr Ishares Put Option (SLV)
Micron Technology (MU)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Echostar Corp Note 3.875%11/3 (Principal)
Anglogold Ashanti Com Shs Call Option (AU)
Tesla Motors Put Option (TSLA)
Gamestop Corp Cl A (GME)
Warner Bros Discovery Com Ser A Call Option (WBD)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Novartis Sponsored Adr (NVS)
Roundhill Etf Trust Memory Etf Call Option

View all positions for LMR Partners

Top funds holding Engene Therapeutics

BVF
Blue Owl Capital Holdings
Caption Management
LMR Partners
Aristeia Capital
D. E. Shaw & Co
Millennium Management
Toronto-Dominion Bank
CSS
Intl Fcstone
Clear Street Group

View all funds holding Engene Therapeutics